OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CDK4/6 Inhibitor Efficacy in ESR1 -Mutant Metastatic Breast Cancer
Maxwell R. Lloyd, Jamie O. Brett, Ariel Carmeli, et al.
NEJM Evidence (2024) Vol. 3, Iss. 5
Closed Access | Times Cited: 4
Maxwell R. Lloyd, Jamie O. Brett, Ariel Carmeli, et al.
NEJM Evidence (2024) Vol. 3, Iss. 5
Closed Access | Times Cited: 4
Showing 4 citing articles:
Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression
J.M. Cejalvo Andujar, Francisco Ayala de la Peña, Mireia Margelí Vila, et al.
Cancer Drug Resistance (2025)
Open Access
J.M. Cejalvo Andujar, Francisco Ayala de la Peña, Mireia Margelí Vila, et al.
Cancer Drug Resistance (2025)
Open Access
Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer – A Clinical Review
C. Benvenuti, Thomas Grinda, Elie Rassy, et al.
Current Treatment Options in Oncology (2024)
Open Access | Times Cited: 1
C. Benvenuti, Thomas Grinda, Elie Rassy, et al.
Current Treatment Options in Oncology (2024)
Open Access | Times Cited: 1
Leveraging Molecular Information for Optimal Treatment Recommendations
Patricia Robinson, William J. Gradishar
NEJM Evidence (2024) Vol. 3, Iss. 5
Closed Access
Patricia Robinson, William J. Gradishar
NEJM Evidence (2024) Vol. 3, Iss. 5
Closed Access
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor–Positive Advanced Breast Cancer
Lis Victória Ravani, Pedro Calomeni, Maysa Vilbert, et al.
JCO Oncology Practice (2024)
Closed Access
Lis Victória Ravani, Pedro Calomeni, Maysa Vilbert, et al.
JCO Oncology Practice (2024)
Closed Access
